datopotamab deruxtecan

Italy

Drugs containing this active substance

  • DATROWAY

    It is used for the treatment of adults with a type of hormone receptor-positive (HR+) and human epidermal growth factor receptor 2 (HER2) negative breast cancer, when the tumor has spread to other parts of the body or cannot be surgically removed.

    Form: powder for concentrate for infusion solution

    Active substance Dosage
    datopotamab deruxtecan -

    ATC: L01FX35

    Manufacturer: DAIICHI SANKYO EUROPE GMBH